Drug Approval | June 12, 2025
Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Zydus receives EIR for the API manufacturing facility at Ankleshwar
GPCB has also asked to submit a bank guarantee of Rs. 2, 00,000 for compliance assurance at the time of revocation and has also ordered to deposit interim environment damage compensation amount
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The inspection of the facility was conducted from August 16-19, 2022.
The plant is expected to start commercial operations from Q4FY24
The facility has the capacity to produce one crore doses per day
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Alkem Medtech to acquire 100% stake of Bombay Ortho
The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and CDMO space
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Subscribe To Our Newsletter & Stay Updated
